Effect of α1-adrenoreceptors stimulation on electrical activity of rat atria

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The effect of methoxamine, an agonist at α1-adrenergic receptors, on the frequency of spontaneous activity and parameters of the electrical activity of the atrial myocardium was investigated in rats with normal sinus rhythm and in normal rats under continuous electrical pacing. Methoxamine exerted dual effects on the duration of repolarization of working cardiomyocytes. Methoxamine increased the duration of the repolarization phase of the action potential in normal rats under continuous electrical pacing but decreased it in rats with normal sinus rhythm.

作者简介

N. Mansour

Kazan Federal University

Email: nourm94@mail.ru
Kazan, Russia

N. Ziyatdinova

Kazan Federal University

Kazan, Russia

A. Gallieva

Kazan Federal University

Kazan, Russia

R. Shakirov

Kazan Federal University

Kazan, Russia

T. Zefirov

Kazan Federal University

Kazan, Russia

参考

  1. R. M. Graham, Cleve Clin. J. Med., 57 (5), 481(1990).
  2. D. M. Perez, Front. Pharmacol., 29, 11 (2020).
  3. R. P. Ahlquist, Am. J. Physiol., 153 (3), 586 (1948).
  4. A. L. Morrow and I. Creese, Mol. Pharmacol., 29 (4), 321 (1986).
  5. D. M. Perez, M. T. Piascik, and R. M. Graham, Mol. Pharmacol., 40 (6),876 (1991).
  6. J. R. Docherty, Eur. J. Pharmacol., 855, 305 (2019).
  7. A. J. Baker, Pflugers Arch., 466 (6), 1139 (2014).
  8. T. L. Zefirov, et al., Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki, 160 (4), 613 (2018).
  9. S. Z. Langer, Biochem. Pharmacol., 23 (13),1793 (1974).
  10. K. B. Lai, J. E. Sanderson, and C. M. Yu, Cardiovasc. Drugs Ther., 23 (4), 271 (2009).
  11. T. D. O'Connell, B. C. Jensen, A. J. Baker, and P. C. Simpson, Pharmacol. Rev., 66 (1), 308 (2014).
  12. K. Nishimaru, M. Kobayashi, T. Matsuda, et al., AJP Heart Circ. Physiol., 280 (1), H132 (2001).
  13. M. Stengl, K. Mubagwa, E. Carmeliet, and W. Flameng, Cardiovasc. Res., 38 (3), 703 (1998).
  14. G. Gambassi, H. A. Spurgeon, E. G. Lakatta, et al., Circ. Res., 71(2), 870 (1992).
  15. A. S. Averin, L. A. Andreeva, S. S. Popova, et al., J.Comp. Physiol. B, 191, 927 (2021).
  16. S. H. Woo and C. O. Lee, Pflugers Arch., 437 (3), 335 (1999).
  17. T. L. Zefirov, I. I. Khabibrakhmanov, N. I. Ziyatdinova, and A. L. Zefirov, Bul. Exp. Biol. Med., 162 (1), 4 (2016).
  18. S. Zhang, R. Takahashi, N. Yamashita, et al., Eur. J. Pharmacol., 839, 82 (2018).
  19. J. M. Nerbonne and R. S. Kass, Physiol. Rev., 85 (4), 1205 (2005).
  20. S. A. Kodirov, V. L. Zhuravlev, T. A. Safonova, et al., Rev. Clin. Pharmacol. Drug Therapy, 3 (4), 27 (2004) [in Russian].
  21. L. Virag, N. lost, M. Opincariu, et al., Cardiovasc. Res., 49 (4), 790 (2001).
  22. E. Grandi, M. C. Sanguinetti, D. C. Bartos, et al., J. Physiol., 595 (7), 2209 (2017).
  23. I. I. Khabibrakhmanov, N. I. Ziyatdinova, and T. L. Zefirov, Russ. J. Cardiol., 26 (5), 53 (2021).

版权所有 © Russian Academy of Sciences, 2023

##common.cookie##